Related Experiment Video
Updated: Jun 3, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in
Petra Zatovkaňuková1, Dalibor Veselý1, Jiří Slíva1
1Department of Pharmacology, Third Faculty of Medicine, Charles University, Ruská 87, 100 00 Prague, Czech Republic.
Paxlovid (nirmatrelvir/ritonavir) is effective for COVID-19, but careful review of drug interactions is crucial, especially in internal medicine and diabetology. This ensures patient safety and optimal treatment outcomes.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- The COVID-19 pandemic necessitated effective antiviral treatments like Paxlovid (nirmatrelvir/ritonavir).
- Assessing drug-drug interactions is vital for safe and effective Paxlovid utilization.
- Understanding interactions with common medications is key for specific medical specialties.
Purpose of the Study:
- To analyze potential drug interactions between Paxlovid and frequently prescribed medications.
- To evaluate the safety profile of Paxlovid in various medical fields.
- To inform clinical practice regarding concurrent medication use with Paxlovid.
Main Methods:
- Retrospective analysis of prescription data from the Czech Republic (4 million COVID-19 patients, 87.5 million medication records).
- Focus on potential interactions between Paxlovid and the 50 most prescribed medications.
- Specific attention to interactions within general medicine, internal medicine, infectious diseases, and diabetology.
Main Results:
- 56% of commonly prescribed drugs showed no interaction with Paxlovid.
- 30% of drugs presented a potential for interaction; 14% were not specified.
- No overall contraindications were identified, but specific interactions were noted in diabetology, infectious diseases, internal medicine, and general medicine.
Conclusions:
- Paxlovid is a valuable early COVID-19 treatment option.
- Careful consideration of potential drug interactions is essential for patient safety.
- Thorough medication assessment is crucial, particularly in high-risk medical specialties, to optimize Paxlovid therapy.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Retrovirus Life Cycles
Therapeutic Index
Factors Affecting Drug Response: Overview
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

